Bilhim, Tiago http://orcid.org/0000-0003-3044-8474
Böning, Georg http://orcid.org/0000-0002-8819-6209
Guiu, Boris
Luz, José Hugo http://orcid.org/0000-0002-1222-850X
Denys, Alban http://orcid.org/0000-0002-2275-7384
Funding for this research was provided by:
Unidade Local de Saúde de São José
Article History
Received: 18 December 2023
Accepted: 20 April 2024
First Online: 17 June 2024
Declarations
:
: Tiago Bilhim is a paid consultant for Merit Medical and has received speaker fees for Philips Medical, Cook Medical, and Terumo and is a stock holder for EmbolX. Boris Guiu is a consultant for Roche, Astra Zeneca, BMS, Boston Scientific, Guerbet, Terumo, and Canon Medical. All other authors declare that they have no conflict of interest.
: All authors had control of the publication.